+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinics. The Clinics: Internal Medicine Volume 20-3

  • Book

  • June 2024
  • Elsevier Health Science
  • ID: 5940130
In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.- Contains 17 relevant, practice-oriented topics including the changing epidemiology of cardiac amyloidosis; arrhythmic stratification of cardiac amyloidosis: state of the art; specific therapy in ATTR-related cardiomyopathy: future perspectives beyond tafamidis; and more.- Provides in-depth clinical reviews on amyloid cardiomyopathies, offering actionable insights for clinical practice.- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Amyloidosis and Amyloidogenesis: One Name, Many Diseases
Pathophysiology of Cardiac Amyloidosis
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis
Clinical Use of Biomarkers in Cardiac Amyloidosis
Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis: Current and Future Clinical Applications
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis
Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update
Standard Therapy in Cardiac Amyloidosis: What is Known, What is “Gray”
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis

Authors

Giuseppe Limongelli University of Campania "Luigi Vanvitelli� Monaldi Hospital,. Michele Emdin Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy, Fondazione Toscana G. Monasterio, CNR-Regione ,Toscana. Marco Merlo Institute of Life Sciences, Scuola Superiore , Sant'Anna, Pisa, Italy, Fondazione Toscana G. Monasterio, CNR-Regione ,Toscana,. Emanuele Monda Department of Translational Medical Sciences, University of Campania, Naples, Italy.